Two receptor pathways are thought to mediate the hepatic clearance of chylomicron remnants, (i) the low density lipoprotein receptor (LDLR) pathway and (ii) non-LDLR pathway. The current study was undertaken to quantitatively assess the contribution of each receptor pathway to hepatic catabolism of chylomicron remnants, by using mice that are deficient in apolipoprotein E (apoE) (apoE(؊/؊)), the LDLR (LDLR(؊/؊)), and both (apoE(؊/؊);LDLR(؊/؊)). Vitamin A fat tolerance tests showed that the area under the curves of the plasma excursions of retinyl ester in the LDLR(؊/؊), apoE(؊/؊), and apoE(؊/؊);LDLR(؊/؊) mice were 4, 12, and 12 times larger than those in wild-type mice. The retinyl ester accumulated in the plasma of the LDLR(؊/؊) mice was distributed in larger subfractions of triglyceride-rich lipoproteins, chylomicrons through very low density lipoprotein-C. These results indicate that the LDLR constitutes the major pathway for the clearance of retinyl ester. In support of this, agarose gel electrophoresis revealed that an oral fat load resulted in retention of chylomicrons in the LDLR(؊/؊) mice, which was not seen in wild-type mice. The observation that the apoE(؊/؊) mice showed larger retinyl ester excursion than LDLR(؊/؊) mice indicates that an apoE-dependent non-LDLR pathway is involved in the rest of the clearance of the retinyl ester. Together, we conclude that the LDLR pathway plays a significant role in the chylomicron remnant metabolism in mice fed a normal chow.In mammals including humans, dietary fat is absorbed by the small intestine, packaged in the chylomicrons, and transported through the lymphatic system to the systemic circulation. Lipoprotein lipase hydrolyzes the core triglycerides of chylomicrons, converting them to chylomicron remnants. The remnants are rapidly cleared by the liver. This step of rapid hepatic clearance has been thought to involve several different processes (for review see Refs. 1-3). The initial process is sequestration of chylomicron remnants into the space of Disse, conceivably through the interaction of apoE on the lipoprotein particles with heparan sulfate proteoglycan (HSPG) 1 on the cell surface (4, 5). Subsequent steps might involve further lipolysis of the remnants by hepatic lipase (6, 7) and acquisition of apoE secreted from the liver (8, 9). The final step appears to involve the cellular uptake of the lipoproteins, mainly by receptor-mediated endocytosis. ApoE is essential for the hepatic removal of chylomicron remnants, as evidently demonstrated by the fact that apoEdeficient humans (10, 11) and mice (12, 13) develop severe plasma retention of chylomicron remnants. As to the role of the low density lipoprotein receptor (LDLR) in the rapid plasma clearance of chylomicron remnants, conflicting results have been reported.Several evidences have suggested that the role of LDLR in the hepatic clearance of chylomicron remnants is marginal, if present. First, in LDLR-deficient humans (14) and rabbits (15), accumulation of chylomicron remnants in the plasma is barely de...